Table 1.
History of acceptance of the Eaton agent as a cause of primary atypical pneumonia.
| Author | Summary |
|---|---|
| Dienes and Edsall (1937) | First isolation of Mycoplasma (Mycoplasma hominis) from humans |
| Reimann (1938) | Recognition of symptoms of “atypical pneumonia” |
| Eaton et al. (1944) | Discovery of Eaton agent |
| Commission on Acute Respiratory Diseases (1945) directed by Dingle et al. | Pinehurst trials: first trial |
| Commission on Respiratory Diseases (1946b,c) directed by Dingle et al. | Pinehurst trials: second trial |
| Commission on Respiratory Diseases (1946b,c) directed by Dingle et al. | Pinehurst trials: third trial |
| Liu et al. (1959) | Establishment of IF technique |
| Liu et al. (1959) | |
| Chanock et al. (1960a) | Eaton agent causes lower respiratory tract infection |
| Chanock et al. (1960b) | Eaton agent grow in cell culture, monkey kidney tissue culture |
| Chanock et al. (1961b) | Eaton agent causes lower respiratory tract infection |
| Clyde et al. (1961) | Fluorescent-stainable antibody to the Eaton agent positive for primary atypical pneumonia |
| Marmion and Goodburn (1961) | Eaton agent is not a virus |
| NIH conference (1961) | Acceptance of Eaton agent as a cause of primary atypical pneumonia |
| Rifkind et al. (1962) | Inoculation of volunteers with Eaton agent |
| Chanock et al. (1962a) | Successful culture of the Eaton agent on cell-free medium |
| Chanock (1963) | Taxonomic designation of M. pneumoniae |